Answer:
patient's history of previous reactions to rituximab or other medications presence of certain medical conditions, or
laboratory results that indicate a high risk of allergic reaction
Step-by-step explanation:
Rituximab targets and binds to a protein called CD20 on the surface of cancer cells, leading to cell death. slows or stops cancer growth.
CD20 is located on mature B cells (white blood cells) in the bone marrow
Rituximab binds to a surface protein, called CD20 Once bound, the antibody activates the body's immune system, which then attacks the cancer cells.
metaAI
cancer.gov